Similarly, in prostate cancer, mTOR inhibition with rapamycin was shown to inhibit VEGF secretion18, however the combined effects of RAD001 and docetaxel on prostate cancer VEGF production were never studied. The gene discussed is VEGFA; the disease is prostate cancer.